Vertigo: Difference between revisions

Jump to navigation Jump to search
Line 19: Line 19:
==Classification==
==Classification==
{| class="wikitable"
{| class="wikitable"
| '''Area of Lesion''' ||  '''Disease''' || '''Main Feature'''  
| '''Area of Lesion''' ||  '''Disease''' || Pathology || '''Main Feature'''  
  |-
  |-
  | Peripheral || Ménière’s disease || recurrent vertigo, aural fullness, hearing loss and [[tinnitus]]
  | Peripheral || Ménière’s disease || Increased [[endolymph]] volume in [[semicircular canals]] || Recurrent vertigo, aural fullness, hearing loss and [[tinnitus]]
  |-
  |-
  | [[Spastic]] || Bilateral [[upper motor neuron]](UMN) || Weakness, [[hyperreflexia]], [[hypertonicity]]
  | [[Spastic]] || Bilateral [[upper motor neuron]](UMN) || Weakness, [[hyperreflexia]], [[hypertonicity]]

Revision as of 16:58, 2 December 2020



Resident
Survival
Guide
Vertigo in Children

Vertigo Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vertigo from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vertigo On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vertigo

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vertigo

CDC on Vertigo

Vertigo in the news

Blogs on Vertigo

Directions to Hospitals Treating Vertigo

Risk calculators and risk factors for Vertigo

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

Synonyms and keywords:

Overview

Historical Perspective

Classification

Area of Lesion Disease Pathology Main Feature
Peripheral Ménière’s disease Increased endolymph volume in semicircular canals Recurrent vertigo, aural fullness, hearing loss and tinnitus
Spastic Bilateral upper motor neuron(UMN) Weakness, hyperreflexia, hypertonicity
Unilateral UMN Unilateral upper motor neuron Weakness, reduced range of motion, decreased fine motor control of tongue & lips
Ataxic Cerebellum Poorly coordinated movements of speech mechanism, scanning/drunken speech
Hyper-kinetic Basal ganglia Quick involuntary movements (hyperkinesis)
Hypo-kinetic Basal ganglia Less movement (hypokinesis), increased muscle tone
Mixed More that one type of dysarthria co-exist Mixed presentation

Pathophysiology

Causes

Differentiating Vertigo from other Diseases

Epidemiology and Demographics

  • Among the patient who presents with dizziness in the primary care setting, fifty-four percent have vertigo upon investigation.[2]

Screening

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Treatment

  1. Labuguen RH (2006). "Initial evaluation of vertigo". Am Fam Physician. 73 (2): 244–51. PMID 16445269.
  2. Kroenke, Kurt (1992). "Causes of Persistent Dizziness". Annals of Internal Medicine. 117 (11): 898. doi:10.7326/0003-4819-117-11-898. ISSN 0003-4819.